Best TWAS P=8.93e-08 · Best GWAS P=1.01e-07 conditioned to 0.138
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Cells Transformed fibroblasts | TGOLN2 | 0.22 | 0.26 | enet | 15 | 0.27 | 2.4e-20 | -5.2 | -5.2 | 1.6e-07 | 0.97 | 0.02 | 0.98 | FALSE |
2 | GTEx | Esophagus Mucosa | TGOLN2 | 0.17 | 0.19 | enet | 15 | 0.18 | 3.0e-12 | -5.1 | -5.2 | 1.7e-07 | 0.97 | 0.02 | 0.98 | FALSE |
3 | GTEx | Esophagus Muscularis | AC093162.5 | 0.14 | 0.09 | lasso | 2 | 0.06 | 1.3e-04 | -5.3 | 5.3 | 1.2e-07 | -0.97 | 0.01 | 0.98 | FALSE |
4 | GTEx | Lung | TGOLN2 | 0.07 | 0.04 | enet | 9 | 0.04 | 6.4e-04 | 5.0 | -5.2 | 1.7e-07 | 0.94 | 0.02 | 0.98 | FALSE |
5 | GTEx | Stomach | TGOLN2 | 0.20 | 0.11 | enet | 14 | 0.11 | 5.4e-06 | -5.2 | -5.2 | 1.7e-07 | 0.93 | 0.02 | 0.98 | FALSE |
6 | GTEx | Whole Blood | RETSAT | 0.13 | 0.08 | lasso | 5 | 0.14 | 8.0e-13 | -4.5 | 5.3 | 8.9e-08 | -0.85 | 0.03 | 0.97 | TRUE |
7 | GTEx | Whole Blood | AC093162.5 | 0.11 | 0.03 | lasso | 2 | 0.01 | 4.0e-02 | -5.3 | 5.3 | 1.1e-07 | -0.97 | 0.01 | 0.98 | FALSE |
8 | NTR | Blood | RETSAT | 0.07 | 0.09 | enet | 21 | 0.09 | 2.9e-28 | -5.2 | 5.1 | 2.9e-07 | -0.97 | 0.01 | 0.98 | FALSE |
9 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TGOLN2 | 0.05 | 0.10 | lasso | 5 | 0.11 | 5.5e-21 | -5.2 | -5.3 | 1.0e-07 | 0.97 | 0.01 | 0.98 | FALSE |
10 | The Cancer Genome Atlas | Colon Adenocarcinoma | TGOLN2 | 0.26 | 0.18 | enet | 14 | 0.15 | 5.1e-09 | -5.2 | -5.2 | 2.3e-07 | 0.89 | 0.02 | 0.98 | FALSE |
11 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | TGOLN2 | 0.13 | 0.18 | enet | 18 | 0.20 | 1.5e-22 | -5.3 | -5.3 | 9.2e-08 | 0.97 | 0.01 | 0.99 | FALSE |
12 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | TGOLN2 | 0.05 | 0.10 | lasso | 1 | 0.09 | 1.1e-10 | -5.2 | -5.2 | 2.1e-07 | 0.97 | 0.02 | 0.98 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | TGOLN2 | 0.09 | 0.09 | lasso | 9 | 0.08 | 2.8e-05 | -5.2 | -5.2 | 2.5e-07 | 0.99 | 0.02 | 0.98 | FALSE |
14 | The Cancer Genome Atlas | Brain Lower Grade Glioma | TGOLN2 | 0.02 | 0.02 | enet | 9 | 0.02 | 7.1e-04 | 5.0 | -5.2 | 2.4e-07 | 0.96 | 0.02 | 0.93 | FALSE |
15 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | TGOLN2 | 0.06 | 0.09 | lasso | 2 | 0.08 | 8.6e-10 | -5.3 | -5.3 | 1.0e-07 | 1.00 | 0.01 | 0.99 | FALSE |
16 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | TGOLN2 | 0.18 | 0.16 | lasso | 6 | 0.16 | 3.5e-11 | -5.3 | -5.3 | 1.1e-07 | 1.00 | 0.01 | 0.99 | FALSE |
17 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | RETSAT | 0.07 | 0.04 | blup | 56 | 0.05 | 4.8e-03 | -4.1 | 5.2 | 2.6e-07 | -0.90 | 0.03 | 0.65 | FALSE |
18 | The Cancer Genome Atlas | Stomach Adenocarcinoma | TGOLN2 | 0.09 | 0.08 | lasso | 9 | 0.08 | 1.1e-06 | -5.3 | -5.3 | 1.1e-07 | 0.99 | 0.02 | 0.98 | FALSE |